- Home
- KLXE vs ECOR Comparison
KLXE vs ECOR Comparison
Compare KLXE & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLXE
- ECOR
- Stock Information
- Founded
- KLXE 2018
- ECOR 2005
- Country
- KLXE United States
- ECOR United States
- Employees
- KLXE N/A
- ECOR N/A
- Industry
- KLXE Oilfield Services/Equipment
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- KLXE Energy
- ECOR Health Care
- Exchange
- KLXE Nasdaq
- ECOR Nasdaq
- Market Cap
- KLXE 35.8M
- ECOR 38.5M
- IPO Year
- KLXE N/A
- ECOR 2018
- Fundamental
- Price
- KLXE $1.96
- ECOR $5.31
- Analyst Decision
- KLXE
- ECOR Strong Buy
- Analyst Count
- KLXE 0
- ECOR 2
- Target Price
- KLXE N/A
- ECOR $25.50
- AVG Volume (30 Days)
- KLXE 113.3K
- ECOR 127.9K
- Earning Date
- KLXE 10-30-2025
- ECOR 08-06-2025
- Dividend Yield
- KLXE N/A
- ECOR N/A
- EPS Growth
- KLXE N/A
- ECOR N/A
- EPS
- KLXE N/A
- ECOR N/A
- Revenue
- KLXE $667,400,000.00
- ECOR $27,700,000.00
- Revenue This Year
- KLXE N/A
- ECOR $24.48
- Revenue Next Year
- KLXE $3.97
- ECOR $44.35
- P/E Ratio
- KLXE N/A
- ECOR N/A
- Revenue Growth
- KLXE N/A
- ECOR 30.16
- 52 Week Low
- KLXE $1.46
- ECOR $4.16
- 52 Week High
- KLXE $7.66
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- KLXE 56.54
- ECOR 44.99
- Support Level
- KLXE $1.87
- ECOR $4.80
- Resistance Level
- KLXE $2.05
- ECOR $5.73
- Average True Range (ATR)
- KLXE 0.14
- ECOR 0.44
- MACD
- KLXE 0.03
- ECOR 0.06
- Stochastic Oscillator
- KLXE 74.29
- ECOR 71.14
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.